Yorktown Management & Research Company’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-11,100
Closed -$445K 389
2018
Q1
$445K Buy
11,100
+5,600
+102% +$233K 0.13% 151
2017
Q4
$237K Hold
5,500
0.07% 346
2017
Q3
$274K Hold
5,500
0.07% 291
2017
Q2
$264K Hold
5,500
0.08% 204
2017
Q1
$249K Hold
5,500
0.06% 261
2016
Q4
$222K Hold
5,500
0.06% 316
2016
Q3
$210K Hold
5,500
0.05% 255
2016
Q2
$230K Hold
5,500
0.05% 247
2016
Q1
$221K Sell
5,500
-40,000
-88% -$1.61M 0.04% 311
2015
Q4
$1.94M Sell
45,500
-10,000
-18% -$460K 0.34% 102
2015
Q3
$2.63M Buy
55,500
+20,000
+56% +$1.02M 0.44% 72
2015
Q2
$1.76M Buy
35,500
+30,000
+545% +$1.52M 0.31% 93
2015
Q1
$272K Hold
5,500
0.05% 280
2014
Q4
$251K Hold
5,500
0.05% 290
2014
Q3
$310K Hold
5,500
0.06% 151
2014
Q2
$292K Hold
5,500
0.05% 218
2014
Q1
$288K Buy
5,500
+500
+10% +$25.3K 0.05% 214
2013
Q4
$268K Hold
5,000
0.05% 261
2013
Q3
$253K Hold
5,000
0.05% 236
2013
Q2
$258K Buy
+5,000
New +$266K 0.05% 191

Other funds holding SNY

Yorktown Management & Research Company's SNY Position: Q2 2018 in Review

Yorktown Management & Research Company sold out of Sanofi (SNY) in Q2 2018, closing a stake of 11,100 shares — an estimated $445K sold.

Yorktown Management & Research Company first reported a position in SNY in Q2 2013 and held it in 20 quarters. The position peaked at $2.63M in Q3 2015. 479 funds tracked by Wall St. Rank hold SNY as of Q2 2018.

  • Yorktown Management & Research Company reported no remaining Sanofi position as of Q2 2018 after selling out during the quarter.
  • Yorktown Management & Research Company sold 11,100 Sanofi shares in Q2 2018, an estimated $445K.
  • Yorktown Management & Research Company first reported a position in Sanofi in Q2 2013 and held it in 20 quarters.
  • Yorktown Management & Research Company's Sanofi position peaked at $2.63M in Q3 2015.
  • 479 funds tracked by Wall St. Rank held Sanofi as of Q2 2018.

Based on Yorktown Management & Research Company's 13F filing for Q2 2018, filed 10 Aug 2018.